BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
China's GLP-1 landscape
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
PFA re-energizes afib market
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Friday, September 20, 2024
See today's BioWorld MedTech
Home
» AOTI raises £35.1M as it debuts on London’s AIM market
X
Upgrade your daily dose of biopharma and medtech news
Subscribe to BioWorld™ news services
See subscription options
To read the full story,
subscribe
or
sign in
.
AOTI raises £35.1M as it debuts on London’s AIM market
June 18, 2024
By
Shani Alexander
No Comments
Advanced Oxygen Therapy Inc. raised £35.1 million (US$44.5 million) in its initial public offering on London’s AIM market. The move by the U.S.-based company is a bid to broaden adoption of its chronic wound care technologies.
BioWorld MedTech
Financings
IPO
Wound closure
Europe